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ABSTRACT 
Background:  
Pain is “an unpleasant sensory and emotional experience associated with 
either actual or potential tissue damage, or described in terms of such damage”. Pre 
emptive analgesia is administration of analgesia prior to the painful stimuli. 
NSAIDS are commonly used medication for the post extraction pain. The 
transdermal NSAIDS have several advantages of higher bioavailability, long 
duration of action, no gastric side effects, controllable drug delivery.  
Objectives:  
The present study was undertaken to compare the efficacy of Transdermal 
Diclofenac and Oral Diclofenac in management of post operative pain in bilateral 
extractions. This study was used to evaluate the post operative pain for the 3 
consecutive post operative days. 
Methods:  
Seventeen healthy patients from both the sexes of age group of 18-55 years 
with bilateral extractions were included in this study. Both the extractions were 
performed under the local anesthesia with one week interval between them.  During 
the first extraction the patient was prescribed preemptively (1 hour before) with the 
study medication of Tab. Diclofenac 50mg thrice daily for three days and during 
second extraction the patient was prescribed with preemptively (2 hours before) with 
Transdermal Diclofenac Diethylamine 100mg patch for three days. The post 
operative pain was recorded in VAS, VRS, PIS, PRS during the post operative 
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period of 2 hours, 6 hours and 12 hours for three consecutive days. Ten paracetamol 
(500 mg) tablets were given to patients as emergency medication. If the patient 
recovered emergency medication, from then the pain scoring was stopped and 
number of paracetamol tablets used is calculated.  
Results:  
Both the diclofenac tablet and diclofenac transdermal patch caused the 
significant reduction in pain scores with time. Though mean pain scores of various 
scales used like VAS, VRS, PIS, PRS for Transdermal patch was lesser than the 
mean pain scores of diclofenac tablet, the difference was not statistically significant. 
Conclusion      
From this study we can arrive at a conclusion that both diclofenac tablet and 
diclofenac transdermal patch are equally effective in management of post extraction 
pain. And Transdermal patch with its various advantages of transdermal delivery 
system can be used as an alternative for oral diclofenac in management of post 
extraction pain.  
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INTRODUCTION 
Pain is a complex, multifaceted experience which  is defined  as “an 
unpleasant sensory and emotional experience associated with either actual or 
potential tissue damage, or described in terms of such damage” by the International 
Association for the Study of Pain.1 
Pain is a predictable part of the postoperative experience. If the post 
operative pain in unrelieved, it may cause clinical as well as psychological changes 
decreasing quality of life and increasing morbidity and mortality.2 
Administration of analgesics before a painful stimulus is Preemptive 
Analgesia. It provides better pain relief better than the same analgesic used after the 
painful stimuli. In early 1980s the concept of pre emptive analgesia was proposed, 
when experimental studies showed, that central hypersensitization can be prevented 
by measures taken prior the onset of painful stimuli, thus reducing the pain post 
operatively.3 
Pain which occurs due to tissue damage modulates the somatosensory 
system, which increases the responsiveness of central and peripheral pain pathways. 
Based on experimental studies it is clear that “prevention” or “pre emption” of 
painful stimuli by analgesics is better than treatment.4 
For ideal postoperative pain management requires elimination of pain and 
discomfort to the patient.5 Nonsteroidal anti-inflammatory drugs (NSAIDs) are most 
commonly used pain medications in dentistry. However, today the NSAIDs toxicity 
is of major concern due to the wide spread use of them.6 
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Analgesic drugs can be administered in a variety of routes, including oral, 
parenteral, inhalation as well as transdermal. Oral route carries the risk of first pass 
metabolism and loss of substantial quantities of the drug before it is absorbed 
systemically. Parenteral administration of drugs can be extremely painful and 
sudden increase in drug concentration in the plasma could lead to certain adverse 
effects.7 
Diclofenac is the commonly prescribed NSAIDS which exhibit anti 
inflammatory, analgesic and anti-pyretic action. When used oral route, however only 
50% of absorbed dose of diclofenac becomes available in the systemic circulation 
after first pass metabolism and also to the high plasma concentration attained, oral 
diclofenac caries the potential for significant adverse reactions particularly involving 
gastrointestinal tract.8 
Transdermal administration has the advantages of being a very easy, simple 
route of administration without the disadvantages of the routes mentioned above and 
also comparatively fewer side effects and complications.7 Transdermal drug delivery 
system can deliver the drugs through the skin portal to systemic circulation at a 
predetermined rate and maintain clinically the effective concentrations over a 
prolonged period of time.9 
In 1970s transdermal patches were developed and the first was approved by 
the FDA in 1979 for the treatment of motion sickness. It was a three-day patch that 
delivered scopolamine. In 1981, patches for nitroglycerin were approved, and today 
there exist a number of patches for drugs such as clonidine, fentanyl, lidocaine, 
nicotine, nitroglycerin, oestradiol, oxybutinin, scopolamine, and testosterone.10  
Introduction 
 
 Page 3 
 
Transdermal patches have the following advantages  
• Transdermal patches are non invasive, painless way to deliver drugs directly 
into the body. 
•  Transdermal patches make the delivery of drugs that are broken down by 
gastric acids, that are inadequately absorbed in small intestine and that are 
extensively metabolised in liver. 
• Transdermal patches deliver the drug over a controlled for long periods of 
time. 
• In transdermal patch it is possible to terminate the delivery of medication 
abruptly.  
• Transdermal patches have fewer side effects than oral medications or 
supplements. 
•  Transdermal patches are patient friendly to use and remember. 
• Extends the activity of drugs having short plasma half-life through the 
reservoir of drug present in the therapeutic delivery system and its controlled 
release characteristics. 
• Transdermal patches are an alternative to patients with cognitive impairment 
or handicapped who cannot self medicate.  
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AIM AND OBJECTIVES 
AIM:       
The aim of the study is to compare the efficacy of transdermal diclofenac 
patch with oral diclofenac tablet in management post extraction pain. 
OBJECTIVE: 
To evaluate post extraction pain relief in patients with transdermal diclofenac 
patch and oral diclofenac tablet. 
. 
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REVIEW OF LITERATURE 
Bhaskar H, Kapoor P, Ragini in 2013 compared the transdermal diclofenac 
patch 100mg with oral diclofenac as an analgesic modality for orthodontic 
extraction in a cross over efficacy trial and evaluated post operative pain in three 
consecutive days in verbal pain intensity scale and pain relief scale in 20 subjects. 
Emergency medication paracetamol tablets were given to the patients with 
transdermal patch. The results showed that the pain intensity scale of both 
transdermal diclofenac patch 100mg and diclofenac tablet showed a gradual 
decrease from day 1 to day 3. The pain relief score showed gradual decrease in both 
transdermal diclofenac patch and oral diclofenac in three days of time. They 
concluded that the transdermal diclofenac 100mg provides as potent analgesia as the 
oral diclofenac tablets with added benefits better patient compliance.19  
Krishnan S et al., in 2015 compared the efficacy of transdermal diclofenac 
and oral diclofenac in post extraction pain management in extraction. They included 
40 patients with unsalvageable non tender molar teeth were divided into case and 
control. The post operative pain was evaluated in 6 hours and 12 hours in Visual 
analog scale. They concluded that the transdermal diclofenac patch showed neither 
statistical nor clinical difference from the efficacy of diclofenac sodium oral tablet in 
management of post operative pain in non tender molar extractions. 23 
Bachalli PS, Nandakumar H, Srinath N in 2009 compared the transdermal 
diclofenac patch 100mg against oral diclofenac 100mg OD for pain control 
following surgical extraction of mandibular impacted third molar in 20 subjects. He 
evaluated the post operative pain in 2 hour, 4 hour, 8 hour, 12 hour, 24 hours in 
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three consecutive days on verbal pain intensity scale and pain relief scale. They 
concluded that the oral diclofenac 100mg was slightly more significant efficacy than 
transdermal diclofenac patch in the first post operative day which was both 
statistically and clinically significant. But in second and third days both transdermal 
diclofenac patch and oral diclofenac were equally effective in post operative pain 
management. Thus concluded that transdermal diclofenac patch can be used as an 
alternative form for oral diclofenac in post operative pain control following the 
removal of impacted mandibular molar, however considering that analgesic potency 
is lesser in immediate post operative period.7  
Bhargava GS, Sidhu AS, Bansal D, Bhatia AS in 2015 compared post 
operative pain with transdermal diclofenac patch and diclofenac intramuscular 
injection after abdominal surgeries in 100 subjects. In this study Transdermal 
diclofenac patch was placed one hour before the end of surgery and Diclofenac 
injection 75mg was given intramuscularly half an hour before the end of surgery. 
They evaluated the post operative pain in immediate post operative period, after 4 
hours, 8 hours, 12 hours and 24 hours in Visual analog scale. They observed that the 
mean time first supplement of analgesia for transdermal diclofenac group was 7.21 
hours and for oral diclofenac it was 7.43 hours. They concluded that Diclofenac 
patch is as effective as Diclofenac intramuscular injection in providing post 
operative analgesia.12 
Krishna R, Natraj MS in 2012 conducted a study on 60 patients, to 
compare the efficacy of single dose of diclofenac patch 100mg with diclofenac 
injection 75mg as a pre emptive post operative analgesia in lower limb surgeries 
under subarachnoid block. The transdermal diclofenac 100mg was given at the 
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beginning of the surgery for the study group and intramuscular diclofenac 75mg was 
given half an hour before the end of the surgery for the control group. Post operative 
pain was evaluated in two hours and six hours in Visual analog scale. The patients 
with VAS score greater than or equal to 5 asked for a rescue anesthesia. The mean 
time for rescue analgesia of injection tramadol 2 mg/kg in control group was 7 hours 
28 minutes and in study group was 8 hours 6 minutes. They concluded that 
transdermal diclofenac patch is as effective as intramuscular diclofenac for acute 
post operative pain, without any side effects.11 
Predel et al in 2003 investigated the safety of transdermal diclofenac patch 
140 mg in treating sports injuries, it was a randomized, placebo controlled, double 
blinded multi center study involving 120 patients. Patient tenderness to pressure was 
evaluated for 7 days twice daily. Patient who received diclofenac 140 mg patch 
showed clinically and statistically reduced pain score, and were free of pain earlier 
than placebo group and it was also supported by Area under Curve of ratio of 
tenderness value comparing injured and contralateral limb. They concluded that 
diclofenac 140 mg patch for acute traumatic blunt soft tissue injuries and they found 
that the diclofenac patch was effective, well tolerated and reported no significant 
adverse events with diclofenac when compared to placebo.20 
Alessandri et al in 2006 studied the efficacy of transdermal diclofenac in 
management of laparoscopic gynaecological surgeries. He divided 120 patients to 
two groups, study transdermal diclofenac and control placebo which was applied 
over the incision site at the end of surgery. The post operative pain intensity was 
evaluated at 6 hours, 12 hours and 12 hours. At 6 hours there was no difference in 
pain intensity between groups but in 12 hours the mean pain intensity score for study 
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group was 3.7 +/- 1.3 and in 24 hours the mean score was 2.0 +/- 0.6. The pain 
intensity score of control group was 5.7 +/- 1.9 and 4.6 +/- 0.5 in 12 hours and 24 
hours respectively. The authors noted that the rate of discharge in patients receiving 
a transdermal diclofenac patch with a standard analgesic was comparable to a 
standard analgesic alone in patients undergoing laparoscopic benign gynaecologic 
surgery. Topical and transdermal preparations are associated with a lower incidence 
of systemic side-effects because of the lower plasma concentration achieved by this 
modes.21 
Lionberger DR and Brennan MJ in 2010 studied the efficacy of diclofenac 
epolamine patch in treating pain due to soft tissue injury and publish a review. He 
reviewed all the randomized studies and meta analysis of Medline database from 
1978 – 2008 based on NSAIDS in soft tissue injuries. They concluded that topical 
NSAID is clinically effective in treating acute pain due to soft tissue injuries, 
producing clinical pain relief from the soft tissue contusions, strains, sprains and 
other localized condition than placebo.22   
Funk et al., in 2008 compared the efficacy of transdermal diclofenac 
hydroxyl pyrolidone with oral diclofenac in management of post arthroscopic pain 
in shoulder joint. They divide 31 patients into two groups namely group one with 17 
patients in whom postoperative medication was tablet diclofenac sodium in 
combination with codeine, paracetamol and group two with 14 patients in whom the 
post operative pain medication was transdermal diclofenac hydroxy pyrolidone in 
combination with codeine, paracetamol. The post operative pain was evaluated in 
Visual analog scale for first 48 hours. The mean pain score at 48 hours was 1.7 in 
diclofenac tablet group and 1.1 for transdermal diclofenac group. They concluded 
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that when used in patients with post operative shoulder pain, both oral and 
transdermal diclofenac showed similar analgesic efficacy. 
Agarwal et al., in 2006 compared the efficacy of EMLA patch and 
transdermal diclofenac patch for intravenous cannulation pain reported that using 
transdermal diclofenac patch for attenuation of venous cannulation. They divided 
450 patients who underwent elective surgery to three groups, namely group one 
control group with placebo patch, group two with EMLA cream, group three with 
diclofenac patch, all the preparations were used at the cannulation site one hour prior 
to cannulation. The cannulation pain was evaluated in visual analog scale. The 
incidence of venous cannulation pain in group one patients was 100%, in group two 
patients was 37% and group three patients was 48%. The median pain score reported 
by the group one patients was 6, group two and three patients were 0. Thus they 
concluded that EMLA and diclofenac patch are equally efficient in controlling the 
venous cannulation pain with transdermal patch having advantage of having 
minimal local side effects.26 
Mason et al., in 2004 in his meta analysis of topical NSAIDS for acute pain 
in 22 double blinded placebo controlled trial were selected from database, he found 
that topical and transdermal preparation caused less side effects and emphasized the 
use of transdermal diclofenac patch in osteo arthritis and sports related injuries.39 
Hsieh et al., in 2010 studied the efficacy and side effects of diclofenac patch 
in treatment of patients with myofacial pain syndrome of trapezius. In this study 
diclofenac sodium patches were compared with control menthol patches in 
randomized, double blind, placebo-controlled trial and the treatment to control ratio 
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was 2:1. Efficacy and safety parameters were assessed before the patch was applied 
(day 0), three days (day4) and seven days after (day8). The findings in this study 
demonstrated that treatment with diclofenac patch produced significantly greater 
pain reduction and earlier mobilization of involved muscles than similar treatment 
with a control menthol patch and the most frequently observed adverse effects in 
either group was skin irritation and erythema: with 16%–18% in the control group 
and 3%–6% in the treatment group. So in overall diclofenac sodium patch was 
superior to placebo in terms of reducing VAS scores and improving functional 
outcomes, and did not cause significant adverse effects. 
Assandri et al. in 1993 evaluated tolerability and pharmacokinetic profile 
for Diclofenac Hydroxy ethyl pyrolidone in both animals and volunteers revealed 
that flexor patch delivered diclofenac at constant level into plasma up to 12 hours 
after application. He also reported that the peak plasma concentration of diclofenac 
after plaster application was about 15 ng ml-1, much lower than that reached by oral 
administration (approximately 1500 ng ml-1), but similar to that reached with a 
topical gel or cream application and estimated absorbed dose of 5-10 mg per 
application appeared to be adequate for the foreseen therapeutic use, with great 
advantage of having no undesirable side effects.32 
Despande et al., reported that pain intensity is decreased during cannulation 
with TDP as shown by VAS score and decreased hemodynamic stress response but 
was not superior to EMLA cream.  Comparison between Diclofenac Transdermal 
Patch Vs Transdermal EMLA cream for attenuation of pain of venous cannulation.  
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Muller et al in 1997 defined diclofenac concentration in tissue layers after 
topical application in 20 individuals. The concentration in the superficial and deep 
layers by use of microdialysis probe into skin 3.9mm and 9.3mm respectively after 
applying the 300mg single dose transdermal patch. The concentration was graphed 
with time profile and the area under curve was found to be 532 +/- 197 µg x min x 
ml(-1) for superficial layers, and 438 +/- 249 µg x min x ml(-1) for deep layers. The 
penetration of TDP, at least after single dose is not predictable and may strongly be 
influenced by individual.29 
Baboota S, Shakeel F and Kohli K in 2006 studied the transdermal 
formulations of diclofenac with permeability enhancers like olesan oil and Dimethyl 
sulfoxide and polymers like carbopol-940, polyvinyl alcohol (PVA), hydroxy propyl 
methyl cellulose-K(4) M, hydroxy propyl cellulose-M, and sodium carboxy methyl 
cellulose. The preparations underwent a series of in physiochemical changes, invitro 
skin permeation studies. They finally concluded Carbopol polymer and Poly vinyl 
alcohol polymer had best permeability when compared to Volteran gel of 
diclofenac.31 
Minghetti P, Cilurzo F, Casiraghi A, Montanari L,  Fini A in 2007 
compared the skin penetration of four salts of diclofenac, diclofenac sodium, 
diclofenac potassium, diclofenac diethylamine, diclofenac epolamine. They 
concluded that aqueous preparation with organic base was the best preparation of 
diclofenac.27 
 Bailey et al., in 1993 in compared the efficacy of dilcofenac 50mg tid and 
aspirin 600mg in management of postoperative pain third molar extractions in a 
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double blinded study with 136 patients. Patients with diclofenac dispersible tablets 
showed decrease in pain intensity. They concluded that aspirin and diclofenac 
dispersible tablets are equally efficient in post extraction pain and diclofenac was 
superior to soluble aspirin in terms of extent of mouth-opening achieved after 
extraction of impacted third molars.34 
Bamgbose BO in 2006 conducted a prospective, randomized study 
comparing the effects of dexamethasone 8 mg IM and Diclofenac potassium 50 mg 
par oral (PO), dexamethasone 8 mg IM and acetaminophen 1000 mg PO, and 
monotherapy with Diclofenac K 50 mg PO on postoperative pain, swelling, and 
trismus after surgical removal of third molars in 150 patients. The post operative 
pain was evaluated in pain intensity scale and swelling was evaluated from the 
measure of tragus to gonion and tragus to opposite tragus. They reported that pain 
was nil in most of patients with diclofenac and dexamethasone compared to other 
group and swelling was less in the group with diclofenac and dexamethasone and in 
group with dexamethasone. Thus concluded that Diclofenac potassium and 
dexamethasone combination provided additional benefits from swelling instead pain 
management alone after third molar extraction.35 
Lopez Carriches C, Martinez Gonzalez JM, Donado Rodriguez in 2005 
compared the efficacy of methylprednisolone 4mg TDS and diclofenac sodium 
50mg TDS in management of trismus in lower third molar extraction in 73 patients. 
The trismus was evaluated by three measurements tragus to angle of the mouth, 
tragus to pogonion and corner of eye to angle of mouth. They concluded that anti 
inflammatory efficacy of oral diclofenac sodium and methyl prednisolone was equal 
in management of post operative trismus in lower third molar extractions.28 
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Niethard FU, Gold MS, Solomon GS, Liu JM, Unkauf M, Albrecht HH  
and Elkik F in 2005 conducted a double blinded placebo controlled study of 
transdermal diclofenac gel in osteoarthritis of knee in 238 patients. Mild difference 
was seen in pain relief between placebo and diclofenac gel in first week and peak 
difference was observed in second week. Thus they concluded that transdermal 
diclofenac gel was superior pain relief and lack side effects in managing the 
osteoarthritis pain management.30  
Arora P and Mukherjee B in 2002 studied the design, development, 
physicochemical, and In vitro and In vivo evaluation of transdermal patches 
containing diclofenac diethylammonium salt with polymers like polyvinyl 
pyrollidone and ethyl cellulose. Based on in vitro studies and in vivo studies in rat it 
was found that PVP:EC 1:2 showed best permeation properties along with pain 
relief than other ratios of 1:4,1:5.36 
Joshi et al., in 2004 compared the efficacy of diclofenac sodium 100mg, 
ibuprofen 600mg, paracetamol 1g with codeine 60mg and placebo when given 
preoperatively. They conducted a double blinded randomised study in 119 patients 
who required surgical extraction of third molar under general anesthesia as a day 
care surgery. The post operative pain was evaluated in Visual analog scale and 
verbal rating scale at 15 minutes , 30 minutes, 1hour, 3 hours, 6 hours and 24 hours.  
The median time of requirement of additional post operative analgesics was 
17minutes for placebo and 32 for diclofenac group. Thus concluding that the 
efficacy of single preoperative dose of diclofenac 100mg, paracetamol 1g, ibuprofen 
600mg was equally effective as codeine 60mg in post operative pain management 
after removal of impacted third molars.24  
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Zuniga JR et al., in 2004 studied the efficacy of diclofenac sodium 100mg 
soft gel and diclofenac potassium 100mg in management of post operative pain in 
third molar extractions. They devised a single blind randomised three armed study 
for comparing diclofenac sodium 100mg soft gel, diclofenac potassium 100mg 
tablet and placebo. They evaluated post operative pain in pain intensity scale and 
pain relief scale at 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 8, and 24 hours post dosing. 
They found that the median onset of action for diclofenac soft gel was 18 minutes 
and the median duration of action is 5 hours and the median onset of action of 
diclofenac potassium was 38 minutes and median duration of action was 4.5hours. 
They concluded that the in acute pain situation, the rapid absorption of nonsteroidal 
anti-inflammatory drugs from a formulation like the Softgel diclofenac sodium may 
relieve pain more efficiently than other preparations.25  
Khalili S et al., in 2014 compared transdermal diclofenac and EMLA in 
double blinded placebo controlled study for venous cannulation in 90 patients 
undergoing elective surgery. The pain was evaluated in visual analog scale, and 
mean score was 4.66, 2.3, 1.76 for placebo, EMLA and transdermal diclofenac. 
Thus concluded that transdermal diclofenac and EMLA is equally efficient in 
managing pain during venous cannulation.33 
Reddy RP et al in 2015 compared the efficacy of transdermal diclofenac 
with intramuscular diclofenac in ingunal hernia mesh repair surgeries in 60 
randomised patients. The intramuscular diclofenac 75mg and transdermal diclofenac 
diethylamine was given one hour after initiating spinal anesthesia. The post 
operative pain was evaluated in visual analog scale in 2hours, 4hours, 6hours, 
12hours, 18hours and 24hours after surgery and rescue medication was inj 
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butrophanol 2mg. the mean time of rescue medication for intramuscular diclofenac 
group was 7.45 hours and for transdermal patch group it was 17.76 hours. Thus 
concluded that transdermal diclofenac is more efficient in post operative pain 
management in hernia repair surgeries.37  
Barrows NR et al., in 2015 studied the transdermal delivery of diclofenac 
potassium by a Natural rubber latex biomembrane as a carrier. X ray distraction 
Study showed non crystalinity of the diclofenac potassium thus the particles are of 
micro sizes 5-6microns. Fourier transform infrared spectroscopy indicated that 
diclofenac potassium do not interact with Natural rubber latex. Scanning electro 
microscope photograph detected drug in both side thus giving uniform release of the 
drug through the rubber latex. They concluded that diclofenac potassium natural 
rubber latex patch releases 20% of diclofenac for a longer duration of 9 days.38 
Osmani R et al., introduced a microsponge based drug delivery system of 
diclofenac in 2015. The diverse properties of the material like particle size analysis, 
and evaluated for morphology, drug loading, in vitro drug release and ex 
vivo diffusion as well.  In vitro drug release results depicted that microsponges with 
1:2 drug–polymer ratio were more efficient to give extended drug release of 75.88% 
at the end of 8 hours and conventional formulation get exhausted incredibly earlier 
by releasing 81.11% drug by 4 hours. Thus, they formulated an effective 
transdermal route with microsponges for osteoarthritis. 
Narzaree P, Griwan MS, Sign J in 2016 compared the efficacy of 
transdermal diclofenac and intramuscular diclofenac for management of post 
operative pain in inguinal hernia surgery. The transdermal patch was applied 3hours 
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prior to surgery and two doses of diclofenac intramuscular injection was given at 
2hours and 12 hours after the surgery. The post operative pain was evaluated in 
Visual analog scale and verbal rating scale every six hours for 24 hours and the pain 
score of 5 was decided to be treated with tramadol 50mg slow intravenous infusion. 
The VAS score obtained at 24 hours showed statistically significant difference 
between the two groups. The mean pain score as assessed by VRS score in 
diclofenac transdermal patch group i.e. for group 2 was 1.60±0.09, 1.06±0.46, 
1.03±0.03 and 1.40±0.09 at 6, 12, 18 and 24 hours respectively. While mean VRS 
score for group 1 i.e. diclofenac intramuscular group was 1.53±0.09, 1.03±0.03, 
1.00±0.00 and 1.13±0.06 at 6, 12 18 and 24 hours respectively. They concluded that 
when applied three hour before surgery transdermal diclofenac was found to be 
equally efficient with intra muscular diclofenac.40 
Verma R, Kumar S, Goyal A, Ajay C. in 2016 compared the efficacy of 
transdermal diclofenac diethylamine 100mg with transdermal ketoprufen 20mg for 
post operative pain management in lower limb surgeries. They included 60 patients 
requiring orthopedic surgeries and divided into two groups, group D received 
transdermal diclofenac and group K received transdermal ketoprufen. The post 
operative pain was evaluated in Visual analog scale at immediate, 1hour, 2hours, 
4hours, 8 hours, 12 hours, 16hours, 20 hours, 24 hours. The patients with pain score 
more than or equal to four were administered injection tramadol 100mg. In group D 
the post operative VAS was 2.4±0.72 and in group K, post operative VAS was 
1.4±0.3 which was significantly low when compared to group D. Only 3 patients 
required rescue analgesia in group K and 11 patients required rescue analgesia I 
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group D. They concluded that transdermal diclofenac and transdermal ketoprufen 
have equal efficacy in managing post operative pain in lower limb surgeries.41 
Arthur AM, Bookman, Williams KSA, Shainhouse JZ in 2004 studied the 
effect of transdermal diclofenac in osteoarthritis pain in 248 patients. It was a 
randomized double blinded placebo controlled study in which group one was 
diclofenac with permeation enhancer dimethyl sulfoxide second group with only 
enhancer and third group with placebo. They reported that 4 weeks of treatment with 
this topical diclofenac solution relieved the symptoms of primary knee osteoarthritis 
significantly better than the vehicle control or placebo solution. The western Ontario 
and mcmaster universities arthritis index subscale scores improved 42.9% for pain, 
39.3% for physical function, 40.5% for stiffness and 44.4% for pain on walking. 
Thus concluded the diclofenac with permeation enhancer dimethyl sulfoxide was 
effective in management of osteo arthritis.42  
Bruhlmann P, Michel BM in 2003 studied the use of topical diclofenac in 
osteo arthritis of knee joint. It was a double blind placebo controlled trial involving 
103 outpatients with osteoarthritis. The parameters evaluated were spontaneous pain 
and lequesne index which were both reduced in topical diclofenac than in placebo. 
They concluded that diclofenac efficient in controlling pain of osteoarthritis in knee 
joint.43 
Kotecha B, Oleary G, Bradburn J, Darowski M and Gwinnutt CL in 
1991 did a study diclofenac sodium intramuscular injection for postoperative pain 
after tonsillectomy. It was a double blinded placebo controlled randomized trial. 
They reported that patients who had diclofenac had lesser pain score and started on 
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liquid diet earlier than placebo group. Thus diclofenac proved to be effective in 
management of post operative pain.44 
Power I, Chambers WA, Greer IA, Ramage D. and Simon E. in 1990 
studied the decrease in platelet aggregation property of diclofenac in 20 
thorocotomy surgery patients. It was a randomized placebo controlled study in 
which diclofenac and placebo was given in the time of anesthesia induction. The 
evaluation factor was bleeding time was checked before and after surgery in which 
diclofenac group had increased bleeding time while the bleeding time remained 
same in placebo.45  
Huskisson EC, Bryans R in 1982 did a double blinded randomized study to 
compare ibuprofen 400mg and diclofenac 50mg tid in stiff shoulder pain. The 
postoperative pain was evaluated in visual analog scale in 40 patients. They 
concluded that ibuprofen and diclofenac were equally efficient in managing pain in 
stiff shoulder.46 
Haynes RJ, Walker S , Kirkpatrick JNP in 1996 studied the use of topical 
diclofenac for corneal rust ring in 40 randomised patients it was a placebo controlled 
study in which one group had topical diclofenac and another group placebo. The 
evaluating criteria was visual analog scale and likert scale. They reported that 
diclofenac had analgesic effect with no change in healing or inflammation.47 
Salmann AR in 1985 in his article about discovery of diclofenac, he 
describes that an effective antirheumatic agent should have the following 
characteristics: an acidity constant between 4 and 5, a partition coefficient of 
approximately 10, and two aromatic rings twisted in relation to each other. The 
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result was diclofenac sodium, which has an acidity constant of 4.0 and a partition 
coefficient of 13.4.48 
Helfgott SM, Sandberg Cook J, Zakim D, Nestler Jin 1990 studied 
Diclofenac sodium hepatic toxicity. It was associated with the development of 
significant hepatitis in seven patients, with one associated death. Signs and 
symptoms developed within several weeks of initiation of drug use and generally 
resolved 4 to 6 weeks following discontinuation of use of the drug. In one patient, 
fatal, fulminant hepatitis developed despite early withdrawal of the drug. It is 
unclear whether the incidence of hepatotoxicity is higher with this drug compared 
with other nonsteroidal anti-inflammatory drugs.49 
Karachalios GN, Fotiadou A, Chrisikos N, Karabetsos A. Kehagioglou 
K in 1992 studied the effectiveness of diclofenac in acute migraine attacks. It was a 
randomized double blinded study in which 86 patients divided into 46 patients with 
diclofenac 75mg intramuscular injection 40 patients with paracetamol 150mg in 40 
patients. The pain relief was achieved within 10 minutes in diclofenac group and in 
38 minutes in paracetamol group. They concluded that diclofenac as efficient in 
managing acute migraine attacks.50 
Gebauer K, Brown P, Varigos G in 2003 studied the efficacy of diclofenac 
in solar keratisis. It was a randomized double blinded placebo controlled study in 
150 patients. After 16 weeks the solar keratosis reduced to 56.1% in diclofenac 
group and 23.4% reduction in placebo. In conclusion, topical 3% diclofenac in 2.5% 
hyaluronan gel was effective and well tolerated for treatment of Solar keratosis.51 
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Baert, Filip, Hart, John, Blackstone, Michael O in 1995 reported a case of 
ulcerative colitis in a 68 aged women with the history of diclofenac medication for 2 
years. The coloscopy showed deep ulcerations in the transverse colon and erythema 
and erosions scattered. All symptoms subsided within 24 h after discontinuation of 
the diclofenac, and follow-up colonoscopy 17 days later showed complete 
endoscopic and histological resolution. Patients and physicians should he aware of 
the possibility of colitis from NSAIDs.52 
Dunk AA, Walt RP, Jenkins WJ, Sherlock SS in 1982 reported a hepatic 
toxicity in a male patient who was under diclofenac medication for osteoarthritis, he 
developed nausea and vomiting, followed within a few days by dark urine, pale 
stools, and jaundice. He was admitted to his local hospital and found to have an 
enlarged liver, palpable 4 cm below the right costal margin; serum liver function 
tests gave results consistent with acute hepatitis. Serum bilirubin concentration was 
126, umol/l (7 4 mg/100 ml) (normal 5-17, umol/l (0-3-1 0 mg/100 ml)) and 
aspartate aminotransferase activity 1375 IU/l (normal 15-40). Tests for hepatitis B 
surface antigen and hepatitis A IgM antibody yielded negative results. Diclofenac 
was withdrawn, and the jaundice resolved completely over seven days, although he 
remained weak and lethargic. On admission to this hospital his liver was enlarged 2 
cm below the right costal margin but there were no signs of chronic liver disease.53 
Romano A, Pietrantonio F, Di Fonso M, Garcovich a, Chiarelli C, 
Venuti a and Barone C in 1994 studied the immune reactions to diclofenac, they 
observed two cases of maculopapular eruptions occurring 48–72 hours after 
administration of diclofenac sodium which had positive patch test. The 
histopathologic findings resembled those of contact dermatitis with different degrees 
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of dermal involvement. This was diagnosed as type IV allergic reaction. Thus 
reinforcing test dose and patch test before prescription of the drug.54 
Verstraeten A, Bakshi R in 1990 studied diclofenac efficacy in traumatic 
joint distortion., 410 patients, predominantly involving the ankle, were recruited for 
treatment with 50 mg diclofenac potassium given orally three times daily for 7 days. 
Significant improvement in mobility, swelling, local tenderness, functional 
impairment and pain intensity occurred after both 3 and 7 days of therapy. Overall 
efficacy was assessed as excellent/good in 83% and 87% of cases by the investigator 
and patient, respectively. Gastrointestinal complaints accounted for around 70% of 
the reported side-effects. In conclusion, diclofenac potassium was both effective and 
well-tolerated when used for the short-term treatment of traumatic joint distortions.55  
Hodsman NBA, Burns J, Blyth A, Kenny GNC, McArdle CS and 
Rotman H in 1987 did a randomized placebo controlled study for analgesic efficacy 
of diclofenac for post operative pain in abdominal surgeries. The emergency 
medication was morphine for both diclofenac and placebo group. The morphine 
consumption reduced in diclofenac for 38.5mg and for placebo is 59.5mg.56 
Mastrolonardo M in 2009 studied the use of diclofenac gel in post 
cryotherapy for actinic keratosis in  29 patients were reviewed after a first-line, 
12 week treatment phase with diclofenac 3% gel alone, the number of Actinic 
keratosis per subject was reduced to an average of 1.5 Actinic keratosis, with 
complete clearance of lesions in 71%. Patients showing incomplete response to the 
above treatment then received liquid-nitrogen ablation for all residual lesions. This 
procedure resulted in complete clearance of all cases. Sequential treatment with 
Review of Literature 
 
 Page 22 
 
diclofenac 3% gel followed by cryotherapy may therefore represent an effective 
approach for the management of multiple refractory actinic keratosis.57 
Sen I, Mitra S, Gombar KK in 2009 reported a fatal anaphylactic reaction 
to oral diclofenac in a nine-year-old girl hospitalised for “transient synovitis”. She 
had no history of atopy or cardio-respiratory illness and her clinical investigations 
were unremarkable. After symptomatic improvement on oral nimsulide and limb 
traction, oral diclofenac 25 mg twice daily was prescribed at discharge. Within 35 
min, she was brought to the ICU gasping, cyanosed, pulseless, with mid-dilated 
weakly reactive pupils and was intubated. Aggressive hemodynamic and respiratory 
support was provided but failed to resuscitate the child. The second dose of 
diclofenac probably lead to a fulminant allergic reaction while delayed 
hospitalisation likely proved fatal. Thus proving the essentiality of a test dose.58 
Preetha JP, Karthika K, Rekha NR, Elshafie K in studied the use of 
diclofenac analgesic in ophthalmic cause. The ocular constraint doesn’t promote the 
drug delivery for a longer duration thus requiring frequent application. The gel 
formulation of diclofenac eliminates the requirement of frequent application. In vitro 
release studies indicated among the all formulations showed better drug release 
when contacted with STF solution at 8 hrs study period. It showed antimicrobial, 
antibacterial and antifungal efficacy with selected microorganisms. These results 
demonstrate that the developed system is an alternative to conventional ophthalmic 
drops, patient compliance, industrially oriented and economical.59 
ALWaili N S in 1986 studied the use of diclofenac in nocturnal enuresis. It 
was a double blinded placebo controlled study. The results showed that 
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prostaglandin levels were low after the diclofenac treatment than placebo. Thus 
diclofenac is used for nocturnal enuresis.61 
Tiwari AK, Tomar GS, Ganguly S, Kapoor MC in 2013 reported kounis 
syndrome after diclofenac therapy. Kounis syndrome" was first described in 1991 by 
Kounis and Zafras. It is also known as "allergic angina syndrome" or "allergic 
myocardial infarction".65 year old patient with planned for procedure ORIF for 
fractured left leg after diclofenac sodium 50 mg intramuscular in the gluteal region, 
developed chest pain and pruritus over the lip along with redness and wheal over the 
site of injection. Electrocardiography (ECG) showed ST-segment elevation in leads 
II, III and avF. An ST-segment elevation myocardial infarction (STEMI) of inferior 
wall was diagnosed and, following primary management, the patient was 
immediately shifted to the intensive care unit and cardiology consultation was 
sought. Detailed physical examination of the patient revealed diffuse erythema and 
rash primarily over the trunk, allergic etiology of the cardiac event was considered 
in view of the clinical history and temporal relationship with intramuscular 
diclofenac sodium injection. They acknowledged the use of test dose before 
diclofenac.62     
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MATERIALS AND METHODS 
Study design: 
This is a comparative interventional study for comparing the efficacy of 
transdermal diclofenac and oral diclofenac in management of post operative pain in 
bilateral extraction. 
Study setting: 
Patients who reported to the Department of Oral and Maxillofacial surgery, 
Sree Mookambika Institute of Dental science, Kulasekharam, Kanyakumari district, 
Tamilnadu were included in the study. Seventeen patients who fulfilled the inclusion 
criteria formed the study sample. 
Number of group: 
Two group. 
Description of group: 
Group1 – patients who received diclofenac tablet for post operative pain during 
tooth extraction in one side of the jaw. 
Group2 – patients who received transdermal diclofenac patch for post operative 
pain during tooth extraction in opposite side of the jaw. 
Sample size of each group: 
 17 patients 
Total sample size of the study 
34 (17 patients) 
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Scientific basis of sample size: 
Quoted from the reference article by Krishna and Natraj MS11 
Formula for sample size  n = 2	
()
()
 
 Where, 
M1 (mean of test intervention) = 118 
M2 (mean of control intervention) = 140 
S1 (standard deviation of M1) = 24.6 
S2 (standard deviation of M2) = 27 
Z1 (Z value associated with alpha) = 1.64 
Z2 (Z value associated with alpha) = 84 
S(pooled standard deviation) = 25.82 
By applying the value in the above formula 
Sample size = 17 per group 
 Sampling technique
 
Convenient sampling technique is used. 
a. Inclusion criteria:  
• Patient in the age group of 18-55 years will be selected irrespective of 
sex, caste, religion and socio-economic status. 
• Bilaterally extraction of same teeth in adjacent quadrants. 
• Patients who agreed to follow the study protocol. 
b. Exclusion criteria:  
• Immunodeficiency pathology. 
• Uncontrolled systemic diseases. 
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• Patient with anti-coagulant therapy. 
• Patient allergic to diclofenac or any NSAIDS 
• Patient under medication of NSAIDS or corticosteroids for any other 
illness. 
• Patient with history of peptic ulcer. 
• Tender teeth and third molars and periodontally compromised teeth.  
•  Uncooperative patients not willing to commit to an appropriate post 
procedure follow-up. 
c. Drugs used  
• Formulation of the drug: Diclofenac diethylamine - Transdermal patch, 
diclofenac sodium - tablets 
• Name of the drug:  Diclofenac diethylamine, diclofenac sodium tablets  
• Dosage of the drug used: diclofenac diethylamine - 100mg, diclofenac 
sodium – 50mg 
• Frequency of the drug used:  diclofenac diethylamine – once a day, 
diclofenac sodium tablets – thrice a day 
• Route of the drug used: diclofenac diethylamine – transdermal patch 
applied over upper arm, diclofenac sodium – oral. 
• Duration of drug: Diclofenac patch - Once a day for three days, 
Diclofenac tablet – Thrice a day for three days. 
• Steps taken to prevent adverse drug reaction: Diclofenac test dose 
during inclusion of patient in a group. 
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Clinical trial registry of India :  REF/2016/07/011847 
Allocation ratio of different groups : 1:1 
Parameters to be studied  
Post operative pain  
• After 2 hours 
• After 6 hours 
• After 12 hours 
In three consecutive days 
Subjective scales of pain used in the study  
Visual analog scale (0-10) 
Verbal rating scale (0-3) 
Pain relief scale (0-3) 
Pain intensity scale (0-3) 
Method/Technique/instruments/Reagents/Kit: 
• Mouth mirror(sirag  surgical) 
• Straight probes(sirag surgical) 
• Tweezers(sirag surgical) 
• Suction cannula(sirag surgical) 
• Disposable syringes(2 ml) with needles(24 gauge)(Dispovan). 
• Lignox 2%.(Lignocaine2% with adrenaline 1:80,000-Warren indoco) 
• Periosteal elevators No -9(sirag surgical) 
• Extraction Forceps specific to the tooth 
• Sterilized gauze and cotton  
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Drugs  
• Diclo plast 100mg - diclofenac transdermal patch from Zuventus 
Healthcare Ltd – Mumbai – Maharashtra. 
•  Fenac 50 – diclofenac tablets from Ortin Laboratories Ltd – Hyderabad – 
Telangana. 
•  DOLO 500 – paracetamol tablets from Micro Labs Pvt Ltd – Chennai – 
Tamil Nadu. 
• Rantac 150 - Tablet Ranitidine 150mg from JB chemicals and 
Pharmaceuticals Ltd – Chennai – Tamil Nadu. 
• Mox 500 - Capsule amoxicillin 500 mg from Ranbaxy laboratory Pvt Ltd 
– Chennai. 
Procedure in detail: 
After proper case recording and selecting the patients, the procedure is 
thoroughly explained to the patient about the use of transdermal diclofenac patch as 
an alternative for oral diclofenac tablets. Patient is asked to take the preoperative 
diclofenac sodium 50mg tab one hour before the procedure. In Under aseptic 
precautions, armamentaria are prepared for extraction. Of the two teeth to be 
extracted in two quadrants, extraction of one tooth is performed under local 
anesthesia 2% with adrenaline 1:80000 (Lignox 2%) with tablet diclofenac 50mg 
one hour before procedure. Tablet diclofenac sodium 50mg (FENAC 50) tds for 
three days, Tablet Ranitidine 150mg (Rantac 150 - JB chemicals and 
Pharmacueticals Pvt Ltd) bid for three days and Capsule amoxicillin 500 mg 
(Mox 500 – Ranbaxy laboratories) tds for five days if needed are prescribed. 
Tablet Paracetamol 500mg ten in number given to the patients as a rescue 
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medication which can be taken in case of increase in pain. Patient are assigned to 
score the post operative pain three times in a three consecutive days in VAS – 
Visual analog scale, VRS – Verbal response scale, PIS- Pain intensity scale , PRS – 
pain relief scale after 2hours, 6 hours and 12 hours and to stop the scoring, if they 
required the tab paracetamol 500mg for pain control and from then the number of 
paracetamol tablet required is calculated. 
The VAS consists of a l0 cm horizontal or vertical line with the two 
endpoints labeled ‘no pain’ and ‘worst pain ever.’ The patient is required to mark 
the l0 cm line at a point that corresponds to the level of pain intensity he or she 
presently feels, The distance in centimeters from the low end of the VAS and the 
patient’s mark is used as a numerical index of the severity of pain.7 
The Verbal Rating Scale is a four point scale with values assigned ranging 
from 0–3. Comfortable, Mild, Moderate and Severe were the corresponding 
interpretation for the above scores.25 The Pain Intensity Scale is a scale which is 
similar to the Verbal Rating Scale. In this scale, the interpretation for the values was 
‘none, mild, moderate and severe’ for corresponding scores between 0–3.24 The Pain 
Relief Scale is also a four point scale, again with values from 0–3. In this scale, the 
interpretation for the values was complete relief for a score of 0 and no relief for a 
score of 3.24 
Patient is recalled for the next extraction one week for the next extraction. 
Patient is instructed to apply the diclofenac patch (Dicloplast 100mg) over right 
upper arm two hour before procedure and the extraction of tooth in opposite side 
of the jaw is carried out under under local anesthesia 2% with adrenaline 1:80000 
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(Lignox 2%). Capsule Amoxicillin 500 mg (Mox 500) tds for five days is 
prescribed to the patient if needed. Patient is asked to change the patch and exactly 
24 hours once exactly from the time of application for three days.  
Tablet Paracetamol 500mg (DOLO 500) ten in number were given to the 
patients as a rescue medication which can be taken in case of increase in pain.  
Patient are assigned to score the post operative pain three times in a three 
consecutive days in VAS – Visual analog scale, VRS – Verbal response scale, PIS- 
Pain intensity scale, PRS – pain relief scale after 2hours, 6 hours and 12 hours and to 
stop the scoring there after if they required the tab paracetamol 500mg  (DOLO 
500)  for pain control and from then the number of paracetamol tablet required is 
calculated. 
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Figure 1- Dicloplast transermal patch 
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Figure 2 – Contents of the Dicloplast patch 
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Figure 3 – Site of Application of patch in right shoulder  
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RESULTS 
Statistical analysis:  
The data was analyzed by Statistical Package for Social Sciences (SPSS 
16.0) version. Unpaired t test applied to find the statistical significant between 
groups. ANOVA (Post hoc) followed by Dunnet t-test applied to find statistical 
significant between the groups. p value less than 0.05 (p<0.05) considered 
statistically significant at 95% confidence interval.   
 
Table-1: Mean VAS scores between the groups at different time periods  
Groups VAS score (MEAN±SD) 
Day one 2 hours 6 hours 12 hours 
Group-I 4.88±0.60 3.47±0.71 2.52±0.51 
Group-II 3.23±0.43 2.41±0.50 2.11±0.60 
Day two 2 hours 6 hours 12 hours 
Group-I 3.00±0.01 2.64±0.49 2.35±0.49 
Group-II 2.01±0.50 1.58±0.50 1.23±0.43 
Day three 2 hours 6 hours 12 hours 
Group-I 1.35±0.49 0.82±0.52 0.00±0.00 
Group-II 0.58±0.50 0.11±0.33 0.00±0.00 
 
  
 
 
Graph-1: Mean VAS scores between the groups at different time periods
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Table-2: Mean VRS scores between the groups at different time periods  
Groups VRS score (MEAN±SD) 
Day one 2 hours 6 hours 12 hours 
Group-I 3.00±0.02 2.64±0.49 2.00±0.01 
Group-II 2.52±0.51 2.00±0.01 1.52±0.62 
Day two 2 hours 6 hours 12 hours 
Group-I 2.00±0.01 2.00±0.01 1.47±0.52 
Group-II 1.47±0.51 1.35±0.49 0.52±0.51 
Day three 2 hours 6 hours 12 hours 
Group-I 1.11±0.33 0.23±0.43 0.00±0.00 
Group-II 0.23±0.43 0.00±0.00 0.11±0.33 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Graph-2: Mean VRS scores between the groups at 
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Table-3: Mean PIS scores between the groups at different time periods  
Groups PIS score (MEAN±SD) 
Day one 2 hours 6 hours 12 hours 
Group-I 3.00±0.01 2.64±0.49 2.00±0.01 
Group-II 2.88±0.33 2.00±0.01 1.47±0.51 
Day two 2 hours 6 hours 12 hours 
Group-I 2.05±0.24 2.00±0.01 1.52±0.51 
Group-II 1.47±0.51 1.05±0.24 0.88±0.33 
Day three 2 hours 6 hours 12 hours 
Group-I 1.23±0.43 0.64±0.49 0.00±0.00 
Group-II 0.23±0.43 0.00±0.00 0.11±0.33 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Graph-3: Mean PIS scores between the groups at different time periods
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Table-4: Mean PRS scores between the groups at different time periods  
Groups PRS score (MEAN±SD) 
Day one 2 hours 6 hours 12 hours 
Group-I 3.00±0.01 2.58±0.50 2.00±0.01 
Group-II 2.88±0.33 1.94±0.42 1.52±0.51 
Day two 2 hours 6 hours 12 hours 
Group-I 2.05±0.24 1.88±0.33 1.52±0.51 
Group-II 1.52±0.51 1.11±0.33 0.88±0.32 
Day three 2 hours 6 hours 12 hours 
Group-I 1.23±0.43 0.58±0.50 0.00±0.00 
Group-II 0.35±0.49 0.00±0.00 0.00±0.00 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Graph-4: Mean PRS scores between the groups at different time periods
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Table-5: Comparison of mean scores of different pain scales between the 
groups at 2 hours on day one 
Groups VAS score (MEAN±SD) 
VRS score 
(MEAN±SD) 
PIS score 
(MEAN±SD) 
PRS score 
(MEAN±SD) 
Group-I 4.88±0.60 3.00±0.02 3.00±0.01 3.00±0.01 
Group-II 3.23±0.43 2.52±0.51 2.88±0.33 2.88±0.33 
P value 1.34 1.56 0.67 0.89 
(p>0.05 no significant compared Group-I with group-II) 
 
Table-6: Comparison of mean scores of different pain scales between the 
groups at 6 hours on day one 
Groups VAS score 
(MEAN±SD) 
VRS score 
(MEAN±SD) 
PIS score 
(MEAN±SD) 
PRS score 
(MEAN±SD) 
Group-I 3.47±0.71 2.64±0.49 2.64±0.49 2.58±0.50 
Group-II 2.41±0.50 2.00±0.01 2.00±0.01 1.94±0.42 
p value 0.33 1.03 0.45 0.24 
(p>0.05 no significant compared Group-I with group-II) 
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Table-7: Comparison of mean scores of different pain scales between the 
groups at 12 hours on day one 
Groups VAS score (MEAN±SD) 
VRS score 
(MEAN±SD) 
PIS score 
(MEAN±SD) 
PRS score 
(MEAN±SD) 
Group-I 2.52±0.51 2.00±0.01 2.00±0.01 2.00±0.01 
Group-II 2.11±0.60 1.52±0.62 1.47±0.51 1.52±0.51 
p value 0.44 1.24 1.67 0.54 
(p>0.05 no significant compared Group-I with group-II) 
 
Table-8: Comparison of mean scores of different pain scales between the 
groups at 2 hours on day two 
Groups VAS score (MEAN±SD) 
VRS score 
(MEAN±SD) 
PIS score 
(MEAN±SD) 
PRS score 
(MEAN±SD) 
Group-I 3.00±0.01 2.00±0.01 2.05±0.24 2.05±0.24 
Group-II 2.01±0.50 1.47±0.51 1.47±0.51 1.52±0.51 
p value 1.43 0.44 0.64 0.23 
 (p>0.05 no significant compared Group-I with group-II) 
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Table-9: Comparison of mean scores of different pain scales between the 
groups at 6 hours on day two 
Groups VAS score (MEAN±SD) 
VRS score 
(MEAN±SD) 
PIS score 
(MEAN±SD) 
PRS score 
(MEAN±SD) 
Group-I 2.64±0.49 2.00±0.01 2.00±0.01 1.88±0.33 
Group-II 1.58±0.50 1.35±0.49 1.05±0.24 1.11±0.33 
p value 2.44 1.56 0.45 1.56 
(p>0.05 no significant compared Group-I with group-II) 
 
Table-10: Comparison of mean scores of different pain scales between the 
groups at 12 hours on day two 
Groups VAS score (MEAN±SD) 
VRS score 
(MEAN±SD) 
PIS score 
(MEAN±SD) 
PRS score 
(MEAN±SD) 
Group-I 2.35±0.49 1.47±0.52 1.52±0.51 1.52±0.51 
Group-II 1.23±0.43 0.52±0.51 0.88±0.33 0.88±0.32 
p value 0.44 1.43 1.89 0.35 
(p>0.05 no significant compared Group-I with group-II) 
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Table-11: Comparison of mean scores of different pain scales between the 
groups at 2 hours on day three 
Groups VAS score (MEAN±SD) 
VRS score 
(MEAN±SD) 
PIS score 
(MEAN±SD) 
PRS score 
(MEAN±SD) 
Group-I 1.35±0.49 1.11±0.33 1.23±0.43 1.23±0.43 
Group-II 0.58±0.50 0.23±0.43 0.23±0.43 0.35±0.49 
p value 0.43 1.23 1.56 0.53 
(p>0.05 significant compared Group-I with group-II) 
 
Table-12: Comparison of mean scores of different pain scales between the 
groups at 6 hours on day three 
Groups VAS score (MEAN±SD) 
VRS score 
(MEAN±SD) 
PIS score 
(MEAN±SD) 
PRS score 
(MEAN±SD) 
Group-I 0.82±0.52 0.23±0.43 0.64±0.49 0.58±0.50 
Group-II 0.11±0.33 0.00±0.00 0.00±0.00 0.00±0.00 
p value 0.34 1.56 1.64 0.52 
(p>0.05 no significant compared Group-I with group-II) 
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Table-13: Comparison of mean scores of different pain scales between the 
groups at 12 hours on day three 
Groups VAS score (MEAN±SD) 
VRS score 
(MEAN±SD) 
PIS score 
(MEAN±SD) 
PRS score 
(MEAN±SD) 
Group-I 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 
Group-II 0.00±0.00 0.11±0.33 0.11±0.33 0.00±0.00 
p value 0 1.23 1.67 0 
(p>0.05 no significant compared Group-I with group-II) 
 
Table-14: Comparison of mean pain scores values within the Group-I at 
different time periods day one  
Day one 
Group-I 
VAS score 
(MEAN±SD) 
P 
value 
VRS score 
(MEAN±SD) 
P 
value 
PIS score 
(MEAN±SD) 
P 
value 
PRS score 
(MEAN±SD) 
P 
value 
2 hours 4.88±0.60  3.00±0.02  3.00±0.01  3.00±0.01  
6 hours 3.47±0.71* 0.03 2.64±0.49* 0.02 2.64±0.49* 0.03 2.58±0.50* 0.03 
12 hours 2.52±0.51*,# 0.02 2.00±0.01*,# 0.02 2.00±0.01*,# 0.03 2.00±0.01*.# 0.03 
(*p<0.05 significant compared 2 hours with other time periods. #p<0.05 
significant compared 6 hours with other time periods) 
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Table-15: Comparison of mean pain scores values within the Group-II at 
different time periods day one  
Day one 
Group-II 
VAS score 
(MEAN±SD) 
P 
value 
VRS score 
(MEAN±SD) 
P 
value 
PIS score 
(MEAN±SD) 
P 
value 
PRS score 
(MEAN±SD) 
P 
value 
2 hours 3.23±0.43  2.52±0.51  2.88±0.33  2.88±0.33  
6 hours 2.41±0.50* 0.03 2.00±0.01* 0.03 2.00±0.01* 0.03 1.94±0.42* 0.03 
12 hours 2.11±0.60* 0.03 1.52±0.62*,# 0.02 1.47±0.51*,# 0.02 1.52±0.51* 0.03 
(*p<0.05 significant compared 2 hours with other time periods. #p<0.05 
significant compared 6 hours with other time periods) 
 
Table-16: Comparison of mean pain scores values within the Group-I at 
different time periods day two 
Day one 
Group-I 
VAS score 
(MEAN±SD) 
P 
value 
VRS score 
(MEAN±SD) 
P 
value 
PIS score 
(MEAN±SD) 
P 
value 
PRS score 
(MEAN±SD) 
P 
value 
2 hours 3.00±0.01  2.00±0.01  2.05±0.24  2.05±0.24  
6 hours 2.64±0.49* 0.03 2.00±0.01  2.00±0.01  1.88±0.33  
12 hours 2.35±0.49* 0.03 1.47±0.52*,# 0.03 1.52±0.51*,# 0.03 1.52±0.51*,# 0.03 
(*p<0.05 significant compared 2 hours with other time periods. #p<0.05 
significant compared 6 hours with other time periods) 
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Table-17: Comparison of mean pain scores values within the Group-II at 
different time periods day two 
Day one 
Group-II 
VAS score 
(MEAN±SD) 
P 
value 
VRS score 
(MEAN±SD) 
P 
value 
PIS score 
(MEAN±SD) 
P 
value 
PRS score 
(MEAN±SD
) 
P 
value 
2 hours 2.01±0.50  1.47±0.51  1.47±0.51  1.52±0.51  
6 hours 1.58±0.50* 0.03 1.35±0.49  1.05±0.24  1.11±0.33  
12 hours 1.23±0.43*
,
# 0.03 0.52±0.51*,# 0.02 0.88±0.33*,# 0.02 0.88±0.32*,# 0.02 
(*p<0.05 significant compared 2 hours with other time periods. #p<0.05 
significant compared 6 hours with other time periods) 
 
Table-18: Comparison of mean pain scores values within the Group-I at 
different time periods day three  
Day one 
Group-I 
VAS score 
(MEAN±SD) 
P 
value 
VRS score 
(MEAN±SD
) 
P 
value 
PIS score 
(MEAN±SD
) 
P 
value 
PRS score 
(MEAN±SD) 
P 
value 
2 hours 1.35±0.49  1.11±0.33  1.23±0.43  1.23±0.43  
6 hours 0.82±0.52* 0.03 0.23±0.43* 0.03 0.64±0.49* 0.03 0.58±0.50* 0.03 
12 hours 0.00±0.00*
,
# 0.01 0.00±0.00*
,
# 0.01 0.00±0.00*
,
# 0.01 0.00±0.00*
,
# 0.01 
(*p<0.05 significant compared 2 hours with other time periods. #p<0.05 
significant compared 6 hours with other time periods) 
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Table-19: Comparison of mean pain scores values within the Group-II at 
different time periods day three 
Day 
one 
Group-II 
VAS score 
(MEAN±SD) 
P 
value 
VRS score 
(MEAN±SD
) 
P 
value 
PIS score 
(MEAN±SD
) 
P 
value 
PRS score 
(MEAN±SD) 
P 
value 
2 hours 0.58±0.50  0.23±0.43  0.23±0.43  0.35±0.49  
6 hours 0.11±0.33* 0.03 0.00±0.00* 0.02 0.00±0.00* 0.02 0.00±0.00* 0.02 
12 
hours 0.00±0.00*
,# 0.03 0.11±0.33*
,
# 0.03 0.11±0.33*
,
#
 
0.03 0.00±0.00# 0.02 
 (*p<0.05 significant compared 2 hours with other time periods. #p<0.05 
significant compared 6 hours with other time periods) 
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 INTERPRETATION OF RESULTS 
Table 1: Mean VAS scores between the groups at different time periods. In 
group one, the day one 2hours , 6hours and 12hours mean VAS score were 4.88, 
3.47, 2,52 respectively and day two scores were 3.00,  2.64, 2.35 respectively and 
the day three scores were 1.35, 0.82, 0.00 respectively. In group two, the day one 
2hours, 6hours and 12hours mean VAS score were 3.23, 2.41, 2.11 respectively and 
the day two scores were 2.01, 1.58, 1.23 respectively and day three scores were 
0.58, 0.11, 0.00 respectively. 
Table 2: Mean VRS scores between the groups at different time periods. In 
group one, the day one 2hours , 6hours and 12hours mean VRS score were 3.00, 
2.64, 2.00 respectively and day two scores were 2.00,  2.00, 1.47 respectively and 
the day three scores were 1.11, 0.23, 0.00 respectively. In group two, the day one 
2hours, 6hours and 12hours mean VRS score were 2.52, 2.00, 1.52 respectively and 
the day two scores were 2.00, 2.00, 1.47 respectively and day three scores were 
0.23, 0.00, 0.11 respectively. 
Table 3: Mean PIS scores between the groups at different time periods. In 
group one, the day one 2hours , 6hours and 12hours mean PIS score were 3.00, 2.64, 
2.00 respectively and day two scores were 2.05,  2.00, 1.52 respectively and the day 
three scores were 1.23, 0.64, 0.00 respectively. In group two, the day one 2hours, 
6hours and 12hours mean PIS score were 2.88, 2.00, 1.47 respectively and the day 
two scores were 1.47, 1.05, 0.88 respectively and day three scores were 0.23, 0.00, 
0.11 respectively. 
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Table 4: Mean PRS scores between the groups at different time periods. In 
group one, the day one 2hours , 6hours and 12hours mean PRS score were 3.00, 
2.58, 2.00 respectively and day two scores were 2.05,  1.88, 1.52 respectively and 
the day three scores were 1.23, 0.58, 0.00 respectively. In group two, the day one 
2hours, 6hours and 12hours mean PRS score were 2.88, 1.94, 1.52 respectively and 
the day two scores were 1.52, 1.11, 0.88 respectively and day three scores were 
0.35, 0.00, 0.00 respectively. 
Table 5: Comparison of mean scores of different pain scales between the 
groups at 2 hours on day one. In group one, the mean day one 2 hour VAS, VRS, 
PIS, PRS scores were 4.88, 3.00, 3.00, 3.00 respectively. In group two, the mean day 
one 2 hour VAS, VRS, PIS, PRS scores were 3.23, 2.52, 2.88, 2.88 respectively. 
The differences in mean day one 2 hour pain scores were not statistically significant.  
 Table 6: Comparison of mean scores of different pain scales between the 
groups at 6 hours on day one. In group one, the mean day one 6 hour VAS, VRS, 
PIS, PRS scores were 3.47, 2.64, 2.64, 2.58 respectively. In group two, the mean day 
one 6 hour VAS, VRS, PIS, PRS scores were 2.41, 2.00, 2.00, 1.94 respectively. 
The differences in mean day one 6 hour pain scores were not statistically significant. 
Table 7: Comparison of mean scores of different pain scales between the 
groups at 12 hours on day one  In group one, the mean day one 12 hour VAS, VRS, 
PIS, PRS scores were 2.52, 2.00, 2.00, 2.00 respectively. In group two, the mean day 
one 12 hour VAS, VRS, PIS, PRS scores were 2.11, 1.52, 1.47, 1.52 respectively. 
The differences in mean day one 6 hour pain scores were not statistically significant. 
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Table 8: Comparison of mean scores of different pain scales between the 
groups at 2 hours on day two. In group one, the mean day two 2 hour VAS, VRS, 
PIS, PRS scores were 3.00, 2.00, 2.05, 2.05 respectively. In group two, the mean day 
two 2 hour VAS, VRS, PIS, PRS scores were 2.01, 1.47, 1.47, 1.52 respectively. 
The differences in mean day two 2 hour pain scores were not statistically significant.  
Table 9: Comparison of mean scores of different pain scales between the 
groups at 6 hours on day two. In group one, the mean day two 6 hour VAS, VRS, 
PIS, PRS scores were 2.64 2.00, 2.05, 1.88 respectively. In group two, the mean day 
two 6 hour VAS, VRS, PIS, PRS scores were 1.58, 1.35, 1.05, 1.11 respectively. 
The differences in mean day two 6 hour pain scores were not statistically significant. 
Table 10: Comparison of mean scores of different pain scales between the 
groups at 12 hours on day two. In group one, the mean day two 6 hour VAS, VRS, 
PIS, PRS scores were 2.35 1.47, 1.52, 1.52 respectively. In group two, the mean day 
two 12 hour VAS, VRS, PIS, PRS scores were 1.23, 0.52, 0.88, 0.88 respectively. 
The differences in mean day two 12 hour pain scores were not statistically 
significant. 
Table 11:  Comparison of mean scores of different pain scales between the 
groups at 2 hours on day three. In group one, the mean day three 2 hour VAS, VRS, 
PIS, PRS scores were 1.35, 1.11, 1.23, 1.23 respectively. In group two, the mean day 
three 2 hour VAS, VRS, PIS, PRS scores were 0.58, 0.23, 0.23, 0.35 respectively. 
The differences in mean day three 2 hour pain scores were not statistically 
significant. 
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Table 12: Comparison of mean scores of different pain scales between the 
groups at 6 hours on day three. In group one, the mean day three 6 hour VAS, VRS, 
PIS, PRS scores were 0.82, 0.23, 0.64, 0.58 respectively. In group two, the mean day 
three 6 hour VAS, VRS, PIS, PRS scores were 0.11, 0.00, 0.00, 0.00 respectively. 
The differences in mean day three 2 hour pain scores were not statistically 
significant. 
Table 13:  Comparison of mean scores of different pain scales between the 
groups at 12 hours on day three. In group one, the mean day three 6 hour VAS, 
VRS, PIS, PRS scores were 0.82, 0.23, 0.64, 0.58 respectively. In group two, the 
mean day three 6 hour VAS, VRS, PIS, PRS scores were 0.11, 0.00, 0.00, 0.00 
respectively. The differences in mean day three 2 hour pain scores were not 
statistically significant. 
Table 14:  Comparison of mean pain scores values within the Group-I at 
different time periods day one. The mean day one VAS scores at 2hour, 6hour, 12 
hour in group I were 4.88, 3.47, 2.52 respectively. The mean day one VRS scores at 
2hour, 6hour, 12 hour in group I were 3.00, 2.64, 2.00 respectively. The mean day 
one PIS scores at 2hour, 6 hour, 12 hour in group I were 3.00, 2.64, 2.00 
respectively. The mean day one PRS scores at 2hour, 6 hour, 12 hour in group I 
were 3.00, 2.58, 2.00 respectively. The differences in mean pain score between 
2hour and 6hour; 6hour and 12 hour were statistically significant. 
Table 15: Comparison of mean pain scores values within the Group-II at 
different time periods day one. The mean day one VAS scores at 2hour, 6hour, 12 
hour in group II were 3.23, 2.41, 2.11 respectively. The mean day one VRS scores at 
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2hour, 6hour, 12 hour in group II were 2.52, 2.00, 1.52 respectively. The mean day 
one PIS scores at 2hour, 6 hour, 12 hour in group II were 2.88, 2.00, 1.47 
respectively. The mean day one PRS scores at 2hour, 6 hour, 12 hour in group II 
were 2.88, 1.94, 1.52 respectively. The differences in mean pain score between 
2hour and 6hour; 6hour and 12 hour were statistically significant. 
Table-16: Comparison of mean pain scores values within the Group-I at 
different time periods day two. The mean day two VAS scores at 2hour, 6hour, 12 
hour in group I were 3.00, 2.64, 2.35 respectively. The mean day two VRS scores at 
2hour, 6hour, 12 hour in group I were 2.00, 2.00, 1.47 respectively. The mean day 
two PIS scores at 2hour, 6 hour, 12 hour in group I were 2.05, 2.00, 1.52 
respectively. The mean day two PRS scores at 2hour, 6 hour, 12 hour in group I 
were 2.05, 1.88, 1.52 respectively. The differences in mean pain score in VAS scales 
between 2hour and 6hour were statistically significant. The differences in mean pain 
scores in 6hour and 12 hour of all the scale were statistically significant. 
Table-17: Comparison of mean pain scores values within the Group-II at 
different time periods day two. The mean day two VAS scores at 2hour, 6hour, 12 
hour in group II were 2.01, 1.58, 1.23 respectively. The mean day two VRS scores at 
2hour, 6hour, 12 hour in group II were 1.47, 1.35, 0.52 respectively. The mean day 
two PIS scores at 2hour, 6 hour, 12 hour in group II were 1.47, 1.05, 0.88 
respectively. The mean day two PRS scores at 2hour, 6 hour, 12 hour in group I 
were 1.52, 1.11, 0.88 respectively. The differences in mean pain score in VAS scales 
between 2hour and 6hour were statistically significant. The differences in mean pain 
scores in 6hour and 12 hour of all the scale were statistically significant. 
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Table-18: Comparison of mean pain scores values within the Group-I at 
different time periods day three. The mean day three VAS scores at 2hour, 6hour, 12 
hour in group I were 1.35, 0.82, 0.00 respectively. The mean day three VRS scores 
at 2hour, 6hour, 12 hour in group I were 1.11, 0.23, 0.00 respectively. The mean day 
three PIS scores at 2hour, 6 hour, 12 hour in group I were 1.23, 0.64, 0.00 
respectively. The mean day three PRS scores at 2hour, 6 hour, 12 hour in group I 
were 1.23, 0.58, 0.00 respectively. The differences in mean pain score between 
2hour and 6hour; 6hour and 12 hour of all the scale were statistically significant. 
Table-19: Comparison of mean pain scores values within the Group-II at 
different time periods day three. The mean day three VAS scores at 2hour, 6hour, 12 
hour in group II were 0.58, 0.11, 0.00 respectively. The mean day three VRS scores 
at 2hour, 6hour, 12 hour in group II were 0.23, 0.00, 0.11 respectively. The mean 
day three PIS scores at 2hour, 6 hour, 12 hour in group II were 0.23, 0.00, 0.11 
respectively. The mean day three PRS scores at 2hour, 6 hour, 12 hour in group II 
were 0.35, 0.00, 0.00 respectively. The differences in mean pain score between 
2hour and 6hour; 6hour and 12 hour of all the scale were statistically significant. 
Graph-1: Mean VAS scores between the groups at different time periods 
In group one, the day one 2hours , 6hours and 12hours mean VAS score 
were 4.88, 3.47, 2,52 respectively and day two scores were 3.00,  2.64, 2.35 
respectively and the day three scores were 1.35, 0.82, 0.00 respectively. In group 
two, the day one 2hours, 6hours and 12hours mean VAS score were 3.23, 2.41, 2.11 
respectively and the day two scores were 2.01, 1.58, 1.23 respectively and day three 
scores were 0.58, 0.11, 0.00 respectively. 
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Graph-2: Mean VRS scores between the groups at different time periods 
 In group one, the day one 2hours, 6 hours and 12hours mean VRS score 
were 3.00, 2.64, 2.00 respectively and day two scores were 2.00, 2.00, 1.47 
respectively and the day three scores were 1.11, 0.23, 0.00 respectively. In group 
two, the day one 2hours, 6hours and 12hours mean VRS score were 2.52, 2.00, 1.52 
respectively and the day two scores were 2.00, 2.00, 1.47 respectively and day three 
scores were 0.23, 0.00, 0.11 respectively. 
Graph-3: Mean PIS scores between the groups at different time periods 
. In group one, the day one 2 hours , 6 hours and 12hours mean PIS score 
were 3.00, 2.64, 2.00 respectively and day two scores were 2.05,  2.00, 1.52 
respectively and the day three scores were 1.23, 0.64, 0.00 respectively. In group 
two, the day one 2hours, 6hours and 12hours mean PIS score were 2.88, 2.00, 1.47 
respectively and the day two scores were 1.47, 1.05, 0.88 respectively and day three 
scores were 0.23, 0.00, 0.11 respectively. 
Graph-4: Mean PRS scores between the groups at different time periods 
In group one, the day one 2hours , 6hours and 12hours mean PRS score were 
3.00, 2.58, 2.00 respectively and day two scores were 2.05,  1.88, 1.52 respectively 
and the day three scores were 1.23, 0.58, 0.00 respectively. In group two, the day 
one 2hours, 6hours and 12 hours mean PRS score were 2.88, 1.94, 1.52 respectively 
and the day two scores were 1.52, 1.11, 0.88 respectively and day three scores were 
0.35, 0.00, 0.00 respectively. 
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DISCUSSION 
The word pain is derived from the latin word peona which means 
punishment. The management of post operative pain is a never ending field of 
research, which changes continuously. The pre emptive analgesia which prevents the 
central sensitization is an effective modality in managing the post operative pain. 
Shat et al. showed that diclofenac sodium is more effective when given pre 
emptively. The NSAIDS like diclofenac and ibuprofen are known for their side 
effects of gastric irritation. The enteral route employed in delivering these NSAIDS 
decreases their bioavailability and further for maintaining a steady state plasma level 
of the drug repeated administration are required. The Parenteral route like intra 
venous, intra osseous, intra muscular route which bypasses the first pass mechanism 
are painful on application.  
The transdermal drug delivery system is an effective method of parenteral 
route which doesnot have the above mentioned disadvantages of other system as it 
bypasses the first pass metabolism thus higher bioavailability, is painless, does not 
cause direct gastric irritation, maintains a steady plasma drug level for a long 
duration of time, patient friendly and allows abrupt termination of drug delivery 
once the patch is removed. 
Evaluation of pain is always subjective, but can be evaluated in various 
scales like Visual Analog Scale, Verbal Rating Scale, Pain Intensity Scale and Pain 
Relief Scale. The Visual Analog Scale is a 11 pointed scale from values 0-10 
referring to no pain and worst pain respectively. The other scale like Verbal Rating 
Scale is similar to Visual Analogue Scale in short 4 pointed scale 0-3 indicating “no 
Discussion 
 
 Page 58 
 
pain” to “severe pain” respectively. The Pain Intensity Scale is a scale similar to 
Verbal Rating Scale, with pain score nil pain, mild, moderate and severe pain 
corresponding to values 0-3. The Pain relief scale is the Pain intensity scale in 
reverse with the values 0-3 corresponding to complete relief and no relief 
respectively. 
In this comparative interventional study, the efficacy of Diclofenac tablet 
and Diclofenac transdermal patch in management of post operative pain is compared 
in patients with bilateral teeth extractions. This study being a cross over study all the 
participants were exposed to both the form of drugs (Diclofenac tablet and 
diclofenac patch) within the interval of one week. This study setting provides a 
better platform to avoid biases. As the emergency medication used is Tab 
paracetamol 650mg, the parameters evaluated are postoperative pain score at 
intervals of 2hour,6 hours and 12 hours in following scales like VAS, VRS, PIS, 
PRS in three consecutive days and if the patient required the emergency medication, 
the number of paracetamol tablet consumed is calculated. 
Post operative pain:  
In day one, the mean pain scores in all the pain scales like VAS, VRS, PIS, 
PRS reduced with time in both the groups and the reduction were statistically 
significant in both groups (diclofenac tablet and diclofenac patch). This result was in 
accordance with Bhaskar et al19, where he showed that in comparing post operative 
pain, the mean pain score reduced with time in both the groups.  
 In day one, though the mean 2 hour pain scores in all the scales seems to be 
lesser in group II (diclofenac patch) when compared to group I(diclofenac tablet) the 
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p value was not statistically significant.  Similarly , the mean 6 hour pain scores in 
day one in all the scales seems to be lesser in group II (diclofenac patch) when 
compared to group I(diclofenac tablet) but the p value was not statistically 
significant.  Similarly, the mean 12 hour pain scores in day one in all the scales 
seems to be lesser in group II (diclofenac patch) when compared to group 
I(diclofenac tablet) but the p value was not statistically significant. This result 
obtained in this study is in contradictory to the previous study by Bachalli PS et al.7 
who showed when comparing Diclofenac patch and Diclofenac tablet the diclofenac 
tablet was more effective in managing the post operative pain in first 24 hours. This 
contraindication can be explained with the fact that the analgesics in this study are 
given preemptively. The diclofenac transdermal patch is given 2 hours and 
diclofenac tablet is given one hour before the procedure.  
In day two, the mean pain score in all the pain scales like VAS, VRS, PIS, 
PRS reduced with time in both the groups and the reduction of mean VAS score was 
significant in both groups (diclofenac tablet and diclofeanc patch). In other scales 
like VRS, PIS, PRS the difference in the pain score between 2hour and 6 hour were 
not significant and the difference in mean pain scores between 6hour and 12 hour 
were significant in both groups.  
In day two, though the mean 2 hour pain scores in all the scales seems to be 
lesser in group II (diclofenac patch) when compared to group I (diclofenac tablet) 
the p value was not statistically significant.  Similarly, the mean 6 hour pain scores 
in day one in all the scales seems to be lesser in group II (diclofenac patch) when 
compared to group I (diclofenac tablet) but the p value was not statistically 
significant. Similarly, the mean 12 hour pain scores in day one in all the scales 
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seems to be lesser in group II (diclofenac patch) when compared to group I 
(diclofenac tablet) but the p value was not statistically significant. This result was 
similar to the result obtained by Bachalli PS et al.7 which states that the transdermal 
diclofenac and Oral Diclofenac are equally efficient in managing the post operative 
pain in day two.   
In day three, the mean pain scores in all the pain scales like VAS, VRS, PIS, 
PRS reduced with time in both the groups and the reduction were statistically 
significant in both groups (diclofenac tablet and diclofenac patch). This result was in 
accordance with Bhaskar et al.19, where he showed that in comparing post operative 
pain, the mean pain score reduced with time in both the groups. 
In day three, though the mean 2 hour pain scores in all the scales seems to be 
lesser in group II (diclofenac patch) when compared to group I (diclofenac tablet) 
the p value was not statistically significant.  Similarly, the mean 6 hour pain scores 
in day one in all the scales seems to be lesser in group II (diclofenac patch) when 
compared to group I (diclofenac tablet) but the p value was not statistically 
significant.  Similarly, the mean 12 hour pain scores in day one in all the scales 
seems to be lesser in group II (diclofenac patch) when compared to group I 
(diclofenac tablet) but the p value was not statistically significant.  
In this study no patients required an emergency medication in both Group I- 
diclofenac tablet and Group II - diclofenac patch, but in a comparative interventional 
study of Baskhar et al.19 about one patient out of twenty required emergency 
paracetamol tablet as an emergency medication inspite of transdermal patch. This 
contradiction can be explained by preemptive analgesic principle of this study. 
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In this study both diclofenac tablet and transdermal diclofenac reduces the 
pain score in all the three days without letting the patient to go for an emergency 
pain medication. Though the mean pain scores for the patients in transdermal patch 
are lesser than the pain scores for the patients in diclofenac tablet, the differences 
between them are not statistically significant. Thus leading to the conclusion of 
equal efficacy of the two medication in management of post operative pain. The 
results were similar to the study by Krishnan et al.23 who compared the efficacy of 
transdermal diclofenac and Oral diclofenac in third molar extraction. 
In this study no patients had side effects like gastric irritation from the tablet 
diclofeanac, contradictory to study of Bhaskar et al 19 where he reported that two of 
twenty patients had gastric irritation. This contradiction can be explained by the 
inclusion of tablet Rantidine 150mg BD prescribed along with tablet Diclofenac 
50mg TID. No patients had any allergic or adverse reaction of diclofenac patch, as 
the patients allergic to diclofenac were excluded from the study. 
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SUMMARY AND CONCLUSION 
The post operative pain management is the most critical part of any surgery, 
this includes to the post extraction pain also. In dentistry the post extraction pain is 
being managed by NSAIDs like diclofenac, paracetamol and ibuprufen. The 
NSAIDs are available in enteral and parenteral forms. The transdermal drug delivery 
modality offers many advantages when compared to other parenteral modalities.  
Diclofenac tablet is the most common NSAID used in dentistry for post 
extraction pain. The transdermal diclofenac can be used as a modality to manage the 
post extraction pain in dentistry. The purpose of the study is to compare the efficacy 
of transdermal diclofenac and oral diclofenac in management of post operative pain 
in bilateral extraction. The study was designed as a cross over comparative 
interventional study with the sample size of 17 in each group. 
After proper case selection based on inclusion and exclusion criteria, the 
patients with bilateral extraction underwent one extraction with the tablet Diclofenac 
one hour before surgery (group I) and the pain scores in scales like Visual Analogue 
Scale, Verbal Rating Scale, Pain intensity Scale, Pain relief Scale was recorded at 
the interval of 2hour, 6hours and 12hours for three days. After interval of one week 
the second extraction is done with transdermal patch placed in right shoulder two 
hours before procedure and the post extraction pain was recorded in similar manner. 
In day one, the mean pain score of all the scales decreased with time 
significantly in both the groups. The group II mean pain score at 2hours and 6 hours 
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and 12 hours for all the scales was lesser than the mean pain scores of group II. But 
the difference was not statistically significant. 
 In day two, the mean pain score of VAS scale decreased with time 
significantly in both the groups. The group II mean pain score at 2hours and 6 hours 
and 12 hours for all the scales were lesser than the mean pain scores of group II. But 
the difference was not statistically significant. 
In day three, the mean pain score of all the scales decreased with time 
significantly in both the groups. The group II mean pain scores at 2hours and 6 
hours and 12 hours for all the scales were lesser than the mean pain scores of group 
II. But the difference was not statistically significant. 
Thus according to statistical analysis of this study, it is proved that the 
transdermal diclofenac and Oral diclofenac are equally effective in management of 
post operative pain. 
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CONSENT FORM 
 
PARTICIPANTS CONSENT FORM 
The details of the study have been explained to me in writing and the details 
have been fully explained to me. I am aware that the results of the study may not be 
directly beneficial to me but will help in the advancement or medical sciences. I 
confirm that I have understood the study and had the opportunity to ask questions. I 
understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without the medical care that will 
normally be provided by the hospital being affected. I agree not to restrict the use 
of any data or results that arise from this study provided such a use is only for 
scientific purpose(s). I have been given an information sheet giving details of the 
study. I fully consent to participate in the study titled 
“COMPARATIVE EVALUATION OF TRANSDERMAL DICLOFENAC 
AND ORAL DICLOFENAC IN MANAGEMENT OF POST OPERATIVE IN 
BILATERAL EXTRACTIONS” 
 
Reference no  :          
Address of the participant  : 
Contact number of the participant : 
       Signature / Thumb impression of the participant / 
                               Legal guardian 
Witnesses:       
1. 
2. 
Date: 
Place:  
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SREE MOOKAMBIKA INSTITUTE OF DENTAL SCIENCES 
DEPARTMENT OF ORAL AND MAXILLOFACIAL SURGERY 
 
“COMPARATIVE EVALUATION OF TRANSDERMAL DICLOFENAC 
AND ORAL DICLOFENAC IN MANAGEMENT OF POST OPERATIVE 
PAIN IN BILATERAL EXTRACTIONS” - AN INVIVO STUDY 
 
DATA RECORD SHEET 
 
Reference no  :      Date: 
Age   :      Op.No: 
Sex   : 
 
DAY ONE :  
 
VAS 
(0-10) 
VRS 
(0-3) 
PIS 
(0-3) 
PRS 
(0-3) 
TIME 2 hrs 6 hrs 
12 
hrs 
2 hrs 6 hrs 
12 
hrs 
2 hrs 6 hrs 
12 
hrs 
2 hrs 6 hrs 
12 
hrs 
GROUP 1 
 
 
No. of 
paracetamol 
tablets 
consumed 
            
            
GROUP 2 
 
No. of 
paracetamol 
tablets 
consumed 
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DAY TWO : 
 
VAS 
(0-10) 
VRS 
(0-3) 
PIS 
(0-3) 
PRS 
(0-3) 
TIME 2 hrs 6 hrs 12 hrs 2 hrs 6 hrs 
12 
hrs 2 hrs 6 hrs 
12 
hrs 2 hrs 6 hrs 
12 
hrs 
GROUP 1 
 
 
No. of 
paracetamol 
tablets 
consumed 
            
            
GROUP 2 
 
 
No. of 
paracetamol 
tablets 
consumed 
            
            
 
DAY THREE: 
 
VAS 
(0-10) 
VRS 
(0-3) 
PIS 
(0-3) 
PRS 
(0-3) 
TIME 2 hrs 6 hrs 12 hrs 2 hrs 6 hrs 
12 
hrs 2 hrs 6 hrs 
12 
hrs 2 hrs 6 hrs 
12 
hrs 
GROUP 1 
 
 
No. of 
paracetamol 
tablets 
consumed 
            
            
GROUP 2 
 
No. of 
paracetamol 
tablets 
consumed 
            
            
 
Group1-diclofenac 50mg tablet .   Group2- diclofenac transdermal patch 100mg. VAS - 
visual analogue scale. VRS - Verbal rating scale (0-3) PRS - Pain relief scale PIS - Pain 
intensity scale 
 
Participant’s Signature                        Investigator’s Signature, 
Date: 
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